Key Differences Between 510(k), De Novo, and PMA Regulatory Pathways
Selecting the right FDA regulatory pathway can shape your product timeline, budget, data plan, and market strategy from day one. At MedLaunch, we advise teams to...
How Manufacturing Process Controls Affect Medical Device Compliance
At MedLaunch, we see manufacturing process controls as a direct link between product quality and regulatory compliance. A strong design can still run into trouble if...
How Risk Management Activities Should Be Integrated Throughout Medical Device Development
At MedLaunch, we see proactive risk management as a core part of good medical device development. It supports better design decisions, stronger documentation, and smoother regulatory...
Common Documentation Gaps That Delay Medical Device Regulatory Submissions
At MedLaunch, we see a common pattern behind many delayed regulatory submissions. The issue is often not the product concept or the test plan. It is...
Preparing for the FDA’s 2026 Human Factors Requirements
What the May 2026 FDA human factors guidance means for your medical device 510(k) submission The Food and Drug Administration issued an updated human factors guidance...
What to Expect During an FDA Quality System Inspection
As a medical device developer, when the time comes for an FDA inspection, it is entirely normal to feel a surge of pressure. Complex regulations and...
- 1
- 2
- 3
- 4
- …
- 7
- Go to the next page